KABAKOFF DAVID S
Insider Reports History
- Location
- San Diego, CA
- Signature
- /s/ Steven P. Cobourn, as attorney-in-fact for David S. Kabakoff
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by KABAKOFF DAVID S:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CASTLE BIOSCIENCES INC | Director | Common Stock | 503,577 | $10,252,828 | $20.36 | 17 Jun 2021 | By L.P. |
| CASTLE BIOSCIENCES INC | Director | Restricted Stock Units | 830 | $16,741 | $20.17 | 10 Jun 2021 | Direct |
| CASTLE BIOSCIENCES INC | Director | Stock option (right to buy) | 3,379 | $12,570 | $3.72 | 10 Jun 2021 | Direct |
| NextCure, Inc. | Director | Stock Option (Right to Buy) | 28,050 | 20 Jun 2025 | Direct |
Insider Reports Filed by KABAKOFF DAVID S
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NXTC | NextCure, Inc. | 20 Jun 2025 | 1 | $0 | 4 | Director | 24 Jun 2025, 16:31 |
| NXTC | NextCure, Inc. | 20 Jun 2024 | 1 | $0 | 4 | Director | 21 Jun 2024, 17:04 |
| NXTC | NextCure, Inc. | 22 Jun 2023 | 1 | $0 | 4 | Director | 23 Jun 2023, 16:31 |
| NXTC | NextCure, Inc. | 23 Jun 2022 | 1 | $0 | 4 | Director | 24 Jun 2022, 17:21 |
| NXTC | NextCure, Inc. | 24 Jun 2021 | 1 | $0 | 4 | Director | 28 Jun 2021, 18:15 |
| CSTL | CASTLE BIOSCIENCES INC | 17 Jun 2021 | 1 | -$2,252,088 | 4 | Director | 21 Jun 2021, 17:47 |
| CSTL | CASTLE BIOSCIENCES INC | 10 Jun 2021 | 2 | $0 | 4 | Director | 14 Jun 2021, 16:34 |